Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

BACKGROUND: Combination therapy of irinotecan, folinic acid (FA) and 5-fluorouracil (5-FU) has been proven to be highly effective for the treatment of metastatic colorectal cancer. However, in light of safety and efficacy concerns, the best combination regimen for first-line therapy still needs to b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Teufel, Andreas, Steinmann, Silke, Siebler, Jürgen, Zanke, Christiane, Hohl, Herbert, Adami, Bernd, Schroeder, M, Klein, O, Höhler, Thomas, Galle, Peter R, Heike, Michael, Moehler, Markus
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2004
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC497044/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15265233/
https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2407-4-38
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares